Method for treating amyloid disease
First Claim
Patent Images
1. A polymerized form of an immunogenic modified Aβ
- peptide, which peptide contains Lysine substitutions in amino acid positions corresponding to amino acids 18 and 19 of Aβ
1-42, which polymerized form is soluble, non-fibrillogenic, has molecular weight less than 100 kDa, has the property of eliciting antibodies directed against the abnormal conformation of Aβ
in amyloid plaques and/or in soluble and semi-soluble Aβ
oligomers, and is produced using controlled polymerization of peptide monomers with glutaraldehyde.
2 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to methods for treating human amyloid disease by administration of modified Aβ peptide immunogens.
-
Citations
4 Claims
-
1. A polymerized form of an immunogenic modified Aβ
- peptide, which peptide contains Lysine substitutions in amino acid positions corresponding to amino acids 18 and 19 of Aβ
1-42, which polymerized form is soluble, non-fibrillogenic, has molecular weight less than 100 kDa, has the property of eliciting antibodies directed against the abnormal conformation of Aβ
in amyloid plaques and/or in soluble and semi-soluble Aβ
oligomers, and is produced using controlled polymerization of peptide monomers with glutaraldehyde. - View Dependent Claims (2, 3, 4)
- peptide, which peptide contains Lysine substitutions in amino acid positions corresponding to amino acids 18 and 19 of Aβ
Specification